Regulation and deregulation of mRNA translation during myeloid maturation

Experimental Hematology

Volumn 39, Issue 2, 2011, Pages 133-141

  Khanna Gupta, Arati ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; CCAAT ENHANCER BINDING PROTEIN ALPHA; GAMMA INTERFERON; GENOMIC DNA; GLUTAMYLPROPYL TRANSFER RNA SYNTHETASE; INITIATION FACTOR 4E BINDING PROTEIN; INITIATION FACTOR 4E BINDING PROTEIN 1; INITIATION FACTOR 4E BINDING PROTEIN 2; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MICRORNA; PROTEIN S6; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELF 2ALPHA; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW CELL; CELL MATURATION; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CYTOPLASM; GENE EXPRESSION REGULATION; GENE REPRESSION; GRANULOPOIESIS; HUMAN; INTRACELLULAR TRANSPORT; LEUKEMOGENESIS; MYELOPOIESIS; NEUTROPHIL; NONHUMAN; NUCLEAR EXPORT SIGNAL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS REGULATION; PROTEIN TRANSPORT; REVIEW; RIBOSOME; RNA TRANSLATION; TRANSCRIPTION REGULATION; TRANSLATION DEREGULATION; TRANSLATION INITIATION; TRANSLATION REGULATION;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; MYELOID CELLS; MYELOID PROGENITOR CELLS; PROTEIN BIOSYNTHESIS;

EUKARYOTA;

EID: 78751497385     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.10.011     Document Type: Review

References (47)

1. Van Der Kelen K., Beyaert R., Inzé D., De Veylder L. Translational control of eukaryotic gene expression. Crit Rev Biochem Mol Biol 2009, 44:143-168.
2. Sonenberg N., Hinnebusch A.G. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009, 136:731-745.
3. Sonenberg N., Dever T.E. Eukaryotic translation initiation factors and regulators. Curr Opin Struct Biol 2003, 13:56-63.
4. Gingras A.C., Raught B., Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Gene Dev 2001, 15:807-826.
5. Ma X., Blenis J. Molecular mechanisms of mTOR mediated translational control. Nat Rev Mol Cell Biol 2009, 10:307-318.
6. Wullschleger S., Loewith R., Hall M.N. TOR signalling in growth and metabolism. Cell 2006, 124:471-484.
7. Martin K.A., Blenis J. Coordinate regulation of translation by the PI3-kinase and mTOR pathways. Adv Cancer Res 2002, 86:1-39.
8. Platanias L.C. Mechanisms of type-1 and type-II interferon-mediated signaling. Nat Rev Immunol 2005, 5:375-386.
9. Lee-Fruman K.K., Kuo C.J., Lippincott J., Terada N., Blenis J. Characterization of S6K2, a novel kinase homologous to S6K1. Oncogene 1999, 18:5108-5114.
10. Olson K., Booth G.C., Poulin F., Sonenberg N., Beretta L. Impaired myelopoiesis in mice lacking the repressors of translation initiation, 4E-BP1 and 4E-BP2. Immunology 2009, 128:e376-e384.
11. Grolleau A., Sonenberg N., Wietzerbin J., Beretta L. Differential regulation of 4E-BP1 and 4E-BP2, two repressors of translation initiation, during human myeloid cell differentiation. J Immunol 1999, 162:3491-3497.
12. Ly C., Arechiga A.F., Melo J.V., Walsh C.M., Ong S.T. Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia via the mammalian target of rapamycin. Cancer Res 2003, 63:5716-5722.
13. Xu Q., Simpson S.E., Scialla T.J., Bagg A., Carroll M. Survival of acute myelod leukemia cells requires PI3 kinase activation. Blood 2003, 102:972-980.
14. Culjkovic B., Topisirovic I., Skrabanek L., Ruiz-Gutierrez M., Borden K.L. eIF4E is a central node of an RNA regulon that governs cellular proliferation. J Biol Chem 2006, 175:415-426.
15. Hagner P., Schneider A., Gartenhaus R.B. Targeting the translational machinery as a novel treatment strategy for hematologic malignancies. Blood 2010, 115:2127-2135.
16. Park S., Chapiuis N., Tamburini J., et al. Role of the PI3K/AKT and mTOR pathways in acute myeloid leukemia. Haematologica 2010, 95:819-828.
17. Tamburini J., Green A.S., Bardet V., et al. Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia. Blood 2009, 114:1618-1627.
18. Hinnebusch A. Mechanism and regulation of initiator methionyl-tRNA binding to ribosomes. CSH monographs volume 39: translational control of gene expression 2000, 185-243. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. N. Sonnenberg, J.W.B. Hershey, M.B. Mathews (Eds.).
19. Oldfield S., Jones J., Tanton D., Proud C. Use of monoclonal antibody to study the structure and function of eukaryotic protein synthesis initiation factor eIF2B. Eur J Biochem 1994, 221:399-410.
20. Rousseau D., Kaspar R., Rosenwald I., Gehrke L., Sonenberg N. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc Natl Acad Sci U S A 1996, 93:1065-1070.
21. Ghilardi N., Wiestner A., Skoda R.C. Thrombopoietin production is inhibited by a translational mechanism. Blood 1998, 92:4023-4030.
22. Harigai M., Miyashita T., Hanada M., Reed J.C. A cis-acting element in the BCL-2 gene controls expression through translational mechanisms. Oncogene 1996, 12:1369-1374.
23. Calkhoven C., Müller C., Leutz A. Translational control of C/EBPalpha and C/EBPbeta isoform expression. Gene Dev 2000, 14:1920-1932.
24. Mueller B.U., Pabst T. C/EBPa and the pathophysiology of acute myeloid leukemia. Curr Opin Hematol 2006, 13:7-14.
25. Schuster M., Porse B. C/EBPa: a tumour suppressor in multiple tissues?. Biochim Biophys Acta 2006, 1766:88-103.
26. Fuchs O. Growth-inhibiting activity of transcription factor C/EBPa, its role in hematopoiesis and its tumour suppressor or oncogenic properties in leukaemias. Folia Biologica (Praha) 2007, 53:97-108.
27. Koschmieder S., Halmos B., Levantini E., Tenen D.G. Dysregulation of the C/EBPalpha differentiation pathway in human cancer. J Clin Oncol 2009, 27:619-628.
28. Zhang P, Iwama A, Datta MW, Darlington GJ, Link DC, Tenen DG. Granulocyte development in C/EBP-alpha-/-mice: the role of expression of the IL-6 and G-CSF receptors. 39th Annual Meeting of the American Society of Hematology, San Diego, CA, December 1997; p. 90.
29. Wang N.D., Finegold M.J., Bradley A., et al. Impaired energy homeostasis in C/EBP-alpha knockout mice. Science 1995, 269:1108-1112.
30. Pabst T., Muller B., Zhang P. Dominant negative mutations of CEBPA encodong CCAAT/enhancer binding protein-a (C/EBPa), in acute myeloid leukemia. Nat Genet 2001, 27:263-270.
31. Geletu M., Balkhi M.Y., Peer Zada A.A., et al. Target proteins of C/EBPalphap30 in AML: C/EBPalphap30 enhances sumoylation of C/EBPalphap42 via up-regulation of Ubc9. Blood 2007, 110:3301-3309.
32. Kirstetter P., Schuster M.B., Bereshchenko O., et al. Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell 2008, 13:299-310.
33. Fu C.T., Zhu K.Y., Mi J.Q., et al. An evolutionarily conserved PTEN-C/EBPα-CTNNA1 axis controls myeloid development and transformation. Blood 2010, 115:4715-4724.
34. Perrotti D., Cesi V., Trotta R., et al. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2. Nat Genet 2002, 30:48-58.
35. Manikandan J., Aarthi J.J., Kumar S.D., Pushparaj P.N. Oncomirs: the potential role of non-coding microRNAs in understanding cancer. Bioinformation 2008, 8:330-334.
36. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
37. Calin G., Dumitru C.D., Shimizu M., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002, 99:15524-15529.
38. He L., Thomson J.M., Hemann M.T., et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435:828-833.
39. Pelosi E., Labbaye C., Testa U. MicroRNAs in normal and malignant myelopoiesis. Leukemia Res 2009, 33:1584-1593.
40. Johnnidis J., Harris M.H., Wheeler R.T., et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008, 451:1125-1129.
41. Fazi F., Rosa A., Fatica A., et al. Aminicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005, 123:819-831.
42. Pulikkan J., Dengler V., Peramangalam P.S., et al. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010, 115:1768-1778.
43. Eiring A., Harb J.G., Neviani P., et al. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 2010, 140:652-665.
44. Feng J., Iwama A., Satake M., Kohu K. MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post-transcriptionally downregulating Runx1. Br J Haematol 2009, 145:412-423.
45. Serhan C., Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005, 6:1191-1197.
46. Mukhopadhyay R., Jia J., Arif A., Ray P.S., Fox P.L. The GAIT system: a gatekeeper of inflammatory gene expression. Trends Biochem Sci 2009, 34:324-331.
47. Kapasi P., Chaudhuri S., Vyas K., et al. L13a blocks 48S assembly: role of a general initiation factor in mRNA-Specific translational control. Mol Cell 2007, 25:113-126.